Medication without harm, much work remains to be done
10.3760/cma.j.cn114015-20210615-00677
- VernacularTitle:药无伤害 任重道远
- Author:
Mingzhao XIAO
1
Author Information
1. 重庆医科大学附属第一医院泌尿外科，重庆 400016
- Publication Type:Journal Article
- Keywords:
Patient safety;
Patient harm;
World Health Organization
- From:
Adverse Drug Reactions Journal
2021;23(8):393-395
- CountryChina
- Language:Chinese
-
Abstract:
Patient safety is a serious global public health problem. In March 2017, World Health Organization (WHO) released the 3rd global patient safety challenge: Medication Without Harm, called for reducing serious and avoidable drug-related injuries in all countries by 50% in the next 5 years, and formulated a strategic action framework for medication safety at the same time. In June 2019, WHO released 3 technical reports, including medication safety in high-risk situations, medication safety in polypharmacy, and medication safety in transitions of care, so as to promote countries to take effective planning and actions as soon as possible to solve problems in the field of medication safety. In April 2021, WHO held a " Medication Without Harm" network conference, emphasizing that it′s an arduous and long-term work to achieve the goal. In May 2021, WHO issued the global patient safety action plan 2021—2030, which took medication safety as the most important task in the 3rd strategic goal, and put forward 4 actions for this task: actions for governments, actions for health care facilities and services, actions for stakeholder, and actions for the WHO. China′s National Health Commission issued the notice on further strengthening patient safety management in April 2018, focusing on promoting patient medication safety. The realization of the 3rd global patient safety challenge requires the joint efforts of all countries in the world.
